BioSpace News Archive

Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family Foundation for his scientific computer-and-image-based workflow to optimize knee implant design

- I-Mab to initiate Phase 2 clinical trial in glioblastoma multiforme (GBM) in China - I-Mab and Genexine expand collaboration for development of TJ107/HyLeukin-7™

GetHealthy Network Hosts E-Commerce Supplement Stores with a Network of Over 1,000 Medical Practitioners Nationwide

Incyte announced that it will present at the Goldman Sachs 41st Annual Global Healthcare Conference on Tuesday, June 9, 2020 at 8:00 a.m. ET.

Horizon Therapeutics plc (Nasdaq: HZNP) announced today that multiple case series and studies will be presented at the Annual European Congress of Rheumatology (EULAR 2020), being held virtually June 3 - 6, 2020. Several presentations of clinical trial data and in-practice cases will provide results on KRYSTEXXA

May 21, 2020, Switch Health Holdings Inc. is pleased to announce the launch of its first Mobile Rapid Testing Unit, designed to assist in the fight against COVID-19.

Veracyte, Inc . (Nasdaq: VCYT) announced today that Bonnie H. Anderson, chairman and chief executive officer, is scheduled to present at the Jefferies Virtual Healthcare Conference on Wednesday, June 3, 2020 at 3:30 p.m. Eastern Time. The link to the live audio webcast of the company’s presentation will be available by visiting Veracyte’s website at https://investor.veracyte.com/events-presentations . A

The fast-reacting kit allows users to test surfaces on-site or remotely for Coronavirus in just over an hour, providing validation of companies’ disinfection procedures to create safe conditions and peace of mind for employees and customers

American BriVision Corporation, a clinical stage biopharmaceutical company developing therapeutic solutions in oncology/hematology, CNS and ophthalmology, said its recently announced private placement of 444,445 common shares has been expanded to 890,000 common shares.

UniPath, a Colorado-based provider of subspecialty pathology, clinical and molecular testing services, is now offering COVID-19 testing to employers anxious to safely get their workers back on the job.